Search research articles
Contact Us
Filters
Showing results (91-100 of 380) with videos related to
Page
of 38
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association
|
October 11, 2013
Idiopathic intracranial hypertension: a possible complication in the natural history of advanced prostate cancer
Francesca Valcamonico, Giuseppina Arcangeli, Francesca Consoli, et al.
European Journal of Endocrinology
|
March 27, 2026
Regional Adrenalectomy Completed by Prophylactic Hyperthermic Intraperitoneal Chemotherapy Reduces the Incidence of Local and Peritoneal Recurrence after Curative Surgery for Adrenocortical Carcinoma
Guido Alberto Massimo Tiberio, Giovanni Casole, Debora Cosentini, et al.
Cancers
|
August 1, 2020
Plasmacytoid Dendritic Cell Impairment in Metastatic Melanoma by Lactic Acidosis
Matilde Monti, Raffaella Vescovi, Francesca Consoli, et al.
Endocrine Connections
|
July 15, 2026
Systemic Management of Adrenal Malignancies: Adrenocortical carcinoma and pheochromocytoma/paraganglioma
Jorge H Hernandez-Felix, Marta Lagana, Deborah Cosentini, et al.
Molecular and Cellular Endocrinology
|
September 11, 2013
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines
Antonina Germano, Ida Rapa, Marco Volante, et al.
Endocrine Connections
|
November 8, 2018
Immunotherapy failure in adrenocortical cancer: where next?
Deborah Cosentini, Salvatore Grisanti, Alberto Dalla Volta, et al.
Journal of the National Cancer Institute. Monographs
|
November 2, 2011
Intermediate endpoints of primary systemic therapy in breast cancer patients
Alfredo Berruti, Daniele Generali, Valentina Bertaglia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2017
When Should Everolimus Be Administered in the Natural History of Pancreatic Neuroendocrine Tumors?
Vito Amoroso, Nicola Fazio, Alessandra Mosca, et al.
Molecular and Cellular Endocrinology
|
December 16, 2014
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization
Antonina Germano, Ida Rapa, Marco Volante, et al.
In Vivo (Athens, Greece)
|
January 2, 2023
Gonadal Function in Male Patients With Metastatic Renal Cell Cancer Treated With Sunitinib
Alberto Dalla Volta, Andrea Delbarba, Francesca Valcamonico, et al.
Page
of 38
Search research articles
Search
Showing results (91-100 of 380) with videos related to
Sort By:
Page
of 38
International Journal of Urology : Official Journal of the Japanese Urological Association
|
October 11, 2013
Idiopathic intracranial hypertension: a possible complication in the natural history of advanced prostate cancer
Francesca Valcamonico, Giuseppina Arcangeli, Francesca Consoli, et al.
European Journal of Endocrinology
|
March 27, 2026
Regional Adrenalectomy Completed by Prophylactic Hyperthermic Intraperitoneal Chemotherapy Reduces the Incidence of Local and Peritoneal Recurrence after Curative Surgery for Adrenocortical Carcinoma
Guido Alberto Massimo Tiberio, Giovanni Casole, Debora Cosentini, et al.
Cancers
|
August 1, 2020
Plasmacytoid Dendritic Cell Impairment in Metastatic Melanoma by Lactic Acidosis
Matilde Monti, Raffaella Vescovi, Francesca Consoli, et al.
Endocrine Connections
|
July 15, 2026
Systemic Management of Adrenal Malignancies: Adrenocortical carcinoma and pheochromocytoma/paraganglioma
Jorge H Hernandez-Felix, Marta Lagana, Deborah Cosentini, et al.
Molecular and Cellular Endocrinology
|
September 11, 2013
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines
Antonina Germano, Ida Rapa, Marco Volante, et al.
Endocrine Connections
|
November 8, 2018
Immunotherapy failure in adrenocortical cancer: where next?
Deborah Cosentini, Salvatore Grisanti, Alberto Dalla Volta, et al.
Journal of the National Cancer Institute. Monographs
|
November 2, 2011
Intermediate endpoints of primary systemic therapy in breast cancer patients
Alfredo Berruti, Daniele Generali, Valentina Bertaglia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2017
When Should Everolimus Be Administered in the Natural History of Pancreatic Neuroendocrine Tumors?
Vito Amoroso, Nicola Fazio, Alessandra Mosca, et al.
Molecular and Cellular Endocrinology
|
December 16, 2014
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization
Antonina Germano, Ida Rapa, Marco Volante, et al.
In Vivo (Athens, Greece)
|
January 2, 2023
Gonadal Function in Male Patients With Metastatic Renal Cell Cancer Treated With Sunitinib
Alberto Dalla Volta, Andrea Delbarba, Francesca Valcamonico, et al.
Page
of 38